The CD169 sialoadhesin molecule mediates cytotoxic. T-cell responses to tumour apoptotic vesicles

被引:31
作者
Black, Lane V. C. [1 ]
Saunderson, Sarah C. [1 ]
Coutinho, Frazer P. [1 ]
Muhsin-Sharafaldine, Morad-Remy [1 ]
Damani, Tanvi T. [1 ]
Dunn, Amy C. [1 ]
McLellan, Alexander D. [1 ]
机构
[1] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand
关键词
MARGINAL ZONE; DENDRITIC CELLS; MACROPHAGES; ANTIGENS; CLEARANCE; AUTOANTIBODIES; TOLERANCE; EXOSOMES; RECEPTOR; INNATE;
D O I
10.1038/icb.2015.111
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Apoptosis leads to the fragmentation and packaging of cellular contents into discrete vesicles, a process known as 'blebbing'. Extracellular vesicles express membrane-bound sialic acids, which enable their capture by CD169 (sialoadhesin; Siglec-1) expressing macrophages in the lymph node and spleen. Furthermore, CD169 mediates vesicle trafficking and suppresses the immune response to exosomes a type of extracellular vesicle released from living cells. In this study, we found that CD169(+) macrophages were the predominant splenic macrophage subset responsible for the capture of EL4 lymphoma-derived apoptotic vesicles (ApoVs) from circulation. CD169(-/-) mice had significantly enhanced in vivo cytotoxic T lymphocyte responses to antigen-pulsed ApoVs, indicating a suppressive role for CD169(+) macrophages to ApoV-associated antigen. In contrast to the observed immunogenic role of ApoVs, the co-administration of unpulsed ApoVs with antigen-pulsed dendritic cells (DCs) significantly suppressed DC-mediated cytotoxic response in vivo; however, this occurred independent of CD169 expression. Overall, our results confirm that apoptosis contributes to both tolerance and immunity, as well as establishing CD169 as a critical mediator of the immune response to extracellular vesicles.
引用
收藏
页码:430 / 438
页数:9
相关论文
共 37 条
  • [1] Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
    Albert, ML
    Pearce, SFA
    Francisco, LM
    Sauter, B
    Roy, P
    Silverstein, RL
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) : 1359 - 1368
  • [2] Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies
    Apetoh, Lionel
    Tesniere, Antoine
    Ghiringhelli, Francois
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. CANCER RESEARCH, 2008, 68 (11) : 4026 - 4030
  • [3] CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens
    Asano, Kenichi
    Nabeyama, Ami
    Miyake, Yasunobu
    Qiu, Chun-Hong
    Kurita, Ai
    Tomura, Michio
    Kanagawa, Osami
    Fujii, Shin-ichiro
    Tanaka, Masato
    [J]. IMMUNITY, 2011, 34 (01) : 85 - 95
  • [4] Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells
    Authier, Astrid
    Farrand, Kathryn J.
    Broadley, Kate W. R.
    Ancelet, Lindsay R.
    Hunn, Martin K.
    Stone, Sarrabeth
    McConnell, Melanie J.
    Hermans, Ian F.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (11) : 2566 - 2578
  • [5] CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes
    Barral, Patricia
    Polzella, Paolo
    Bruckbauer, Andreas
    van Rooijen, Nico
    Besra, Gurdyal S.
    Cerundolo, Vincenzo
    Batista, Facundo D.
    [J]. NATURE IMMUNOLOGY, 2010, 11 (04) : 303 - U48
  • [6] Bellone M, 1997, J IMMUNOL, V159, P5391
  • [7] Belz GT, 2002, CRIT REV IMMUNOL, V22, P439
  • [8] Macrophages Discriminate Glycosylation Patterns of Apoptotic Cell-derived Microparticles
    Bilyy, Rostyslav O.
    Shkandina, Tanya
    Tomin, Andriy
    Munoz, Luis E.
    Franz, Sandra
    Antonyuk, Volodymyr
    Kit, Yuriy Ya.
    Zirngibl, Matthias
    Fuernrohr, Barbara G.
    Janko, Christina
    Lauber, Kirsten
    Schiller, Martin
    Schett, Georg
    Stoika, Rostyslav S.
    Herrmann, Martin
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (01) : 496 - 503
  • [9] NK Cells Are Required for Dendritic Cell-Based Immunotherapy at the Time of Tumor Challenge
    Bouwer, Anthea L.
    Saunderson, Sarah C.
    Caldwell, Felicity J.
    Damani, Tanvi T.
    Pelham, Simon J.
    Dunn, Amy C.
    Jack, Ralph W.
    Stoitzner, Patrizia
    McLellan, Alexander D.
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192 (05) : 2514 - 2521
  • [10] Anti-class a scavenger receptor autoantibodies from systemic lupus erythematosus patients impair phagocytic clearance of apoptotic cells by macrophages in vitro
    Chen, Xiao-wei
    Shen, Yan
    Sun, Chuan-yin
    Wu, Feng-xia
    Chen, Yi
    Yang, Cheng-de
    [J]. ARTHRITIS RESEARCH & THERAPY, 2011, 13 (01)